Hikma Pharmaceuticals (OTCMKTS:HKMPF) Sees Large Volume Increase – What’s Next?

Shares of Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF) saw unusually-high trading volume on Monday . Approximately 1,100 shares changed hands during mid-day trading, a decline of 31% from the previous session’s volume of 1,592 shares.The stock last traded at $19.67 and had previously closed at $20.40.

Hikma Pharmaceuticals Trading Up 2.1%

The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33. The business’s 50 day simple moving average is $21.62 and its 200-day simple moving average is $24.11.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.

Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.